Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2012 by State University of New York - Upstate Medical University
Information provided by (Responsible Party):
State University of New York - Upstate Medical University Identifier:
First received: December 12, 2012
Last updated: December 13, 2012
Last verified: December 2012

There is accumulating evidence that genetic expression plays a role in autism spectrum disorder, but the regulation of such genes is poorly understood. Small RNA particles, called microRNA (miRNA), have the ability to alter gene expression. These particles can be packaged and released from brain cells into the blood. Changes in miRNA may contribute to the patterns observed in autism spectrum disorder.

The purpose of this study is to identify small RNA particles that regulate gene expression in autism spectrum disorder. The goal is to identify miRNA expression patterns which may improve our understanding and diagnosis of autism spectrum disorder.

Autism Spectrum Disorder
Exosomal miRNA Expression

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by State University of New York - Upstate Medical University:

Primary Outcome Measures:
  • Exosomal microRNA expression patterns [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Whole Blood

Estimated Enrollment: 40
Study Start Date: January 2013
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Children ages 4-17 years old with DSM-IV defined autism spectrum disorder
Age- and gender-matched controls with typical neuropsychological developmental patterns

  Show Detailed Description


Ages Eligible for Study:   4 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children from the University Pediatric and Adolescent Center and the Center for Development Behavior and Genetics in Syracuse, New York.


Inclusion Criteria:

  • Children ages 4-17

Exclusion Criteria:

  • neurological impairments (i.e. cerebral palsy, epilepsy)
  • sensory deficits (i.e. sensory or visual impairments)
  • psychological disorders (i.e. obsessive compulsive disorder, attention deficit disorder)
  • control subjects with family history of autism spectrum disorder
  • mental retardation
  • history of preterm birth
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01749670

Contact: Steven Hicks, MD, PhD 845 518 0649

United States, New York
SUNY Upstate Medical University Not yet recruiting
Syracuse, New York, United States, 13210
Contact: Steven Hicks, MD, PhD    845-518-0649   
Sponsors and Collaborators
State University of New York - Upstate Medical University
Principal Investigator: Steven Hicks, MD, PhD SUNY Upstate Medical University, Department of Pediatrics
  More Information

No publications provided

Responsible Party: State University of New York - Upstate Medical University Identifier: NCT01749670     History of Changes
Other Study ID Numbers: 346301-1
Study First Received: December 12, 2012
Last Updated: December 13, 2012
Health Authority: United States: Institutional Review Board
United States: Data and Safety Monitoring Board

Keywords provided by State University of New York - Upstate Medical University:
Autism Spectrum Disorder
Exosomal miRNA expression

Additional relevant MeSH terms:
Autistic Disorder
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Pathologic Processes processed this record on November 19, 2014